Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 03, 2026
TickeronGET DAILY SIGNALS
FSTA vs IYK: Weighing Two Consumer Staples ETFs for Defensive Exposure

FSTA vs IYK: Weighing Two Consumer Staples ETFs for Defensive Exposure

Key Takeaways

  • FSTA tracks the broad MSCI USA IMI Consumer Staples 25/50 Index and holds roughly 100 stocks, while IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index with about 58 holdings.
  • FSTA carries an expense ratio of 0.08%, far below IYK's 0.38%, giving FSTA a meaningful structural cost advantage over long holding periods.
  • IYK blends a notable slice of healthcare distribution names such as CVS Health and McKesson into its portfolio, making it a less pure-play consumer staples vehicle than FSTA.
  • Both funds are passively managed, defensive, low-beta strategies concentrated in mega-cap household names, but FSTA is more top-heavy in Walmart, Costco, and Procter & Gamble.
  • Tickeron AI Verdict: FSTA — the AI favors the Fidelity fund for its lower cost, broader diversification, and purer sector exposure.

Setting the Stage for These Staples ETFs

FSTA and IYK stand out as popular choices for U.S. consumer staples exposure, yet they approach the same defensive theme differently. Both give investors a way to own companies providing essential goods like food, beverages, tobacco, and household items, but their underlying indexes, number of holdings, and fee structures set them apart. With factors like inflation trends, rate expectations, and consumer resilience influencing recent cycles, it helps to examine how these funds differ in sector focus, concentration levels, and overall efficiency when considering them side by side.

FSTA: Broad Coverage Across the Staples Universe

FSTA aims to match the MSCI USA IMI Consumer Staples 25/50 Index, a cap-weighted benchmark that spans most of the U.S. staples space. It holds around 100 stocks, extending from large leaders into mid- and smaller-cap names while staying almost entirely within consumer defensive areas. The portfolio leans heavily toward top positions, with Walmart, Costco, and Procter & Gamble together making up more than a third of assets. Other key names include KO, PEP, PM, and MDLZ. Its expense ratio of 0.08% ranks among the lowest available, and the fund has served as a core sector holding for over a decade. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

IYK: A More Concentrated Staples Approach with a Twist

IYK follows the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index and has been around since 2000. It holds roughly 58 securities and qualifies as non-diversified, so exposure sits across fewer names. Top holdings overlap with FSTA but differ in weighting, featuring PG, KO, PM, PEP, and ALT. What sets it apart is the addition of healthcare distribution companies like CVS and MCK, which account for about 11% of the portfolio and move it away from pure staples exposure. The expense ratio is 0.38%.

The Broader Context for Staples Investing

Consumer staples often serve as a steady anchor during uncertain economic times because demand for necessities holds up better than discretionary spending. Recent periods have featured moderating yet persistent inflation, evolving rate outlooks, and mixed consumer sentiment, all of which affect rotations into or out of defensive areas. Within the sector, pricing power and volume trends at major producers have shaped results, while the healthcare names in IYK face separate regulatory pressures. Common risks involve input-cost margins, currency effects for global firms, and shifts in capital toward growth areas when sentiment improves. From what I see, these dynamics make careful comparison worthwhile.

How Performance and Risk Profiles Compare

Both funds have drawn defensive interest lately, though their results have varied based on portfolio makeup. IYK’s healthcare tilt and tobacco emphasis have occasionally supported stronger short-term moves, while FSTA’s broader mega-cap focus has delivered more consistent participation at lower cost. On risk measures, IYK has tended toward lower beta thanks to its healthcare component, whereas FSTA’s emphasis on Walmart and Costco aligns it more with retail trends. Over longer horizons, FSTA’s fee advantage and wider diversification position it as an efficient core holding, even if IYK’s narrower profile can provide distinct tactical exposure at times.

Refining ETF Comparisons with Data Tools

When evaluating options like these, I find it useful to run quick scans across multiple factors. Tickeron’s AI Screener lets me filter by industry, expense ratios, holding counts, and performance metrics in one place. This helps highlight structural differences without manual effort and supports more informed decisions on sector allocations.

Tickeron AI Verdict

Structural details point to a preference for FSTA over IYK. The lower expense ratio, larger and more diversified holdings, and cleaner staples focus without the healthcare overlay give it an edge for core, long-term exposure. While IYK can show competitive short-term momentum, FSTA’s efficiency and consistency as a true sector benchmark make it the stronger choice for most investors seeking steady defensive positioning. This view comes from data-driven analysis and is not personalized advice.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IYK, FSTA

IYK's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 70 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.

Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Bearish Trend Analysis

The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 30 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 61 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

IYK broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Philip Morris International (NYSE:PM), PepsiCo (NASDAQ:PEP), Altria Group (NYSE:MO), McKesson Corp (NYSE:MCK), CVS HEALTH Corp (NYSE:CVS), Mondelez International (NASDAQ:MDLZ), Colgate-Palmolive Company (NYSE:CL), Kroger Co (The) (NYSE:KR).

Industry description

The investment seeks to track the investment results of the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index composed of U.S. equities in the consumer staples sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index, The underlying index measures the performance of the consumer staples sector of the U.S. equity market. It is non-diversified.

Market Cap

The average market capitalization across the iShares U.S. Consumer Staples ETF (IYK) ETF is 49.58B. The market cap for tickers in the group ranges from 3.34B to 412.31B. KO holds the highest valuation in this group at 412.31B. The lowest valued company is FRPT at 3.34B.

High and low price notable news

The average weekly price growth across all stocks in the iShares U.S. Consumer Staples ETF (IYK) ETF was 9%. For the same ETF, the average monthly price growth was 29%, and the average quarterly price growth was 59%. TAP experienced the highest price growth at 8%, while SFM experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the iShares U.S. Consumer Staples ETF (IYK) ETF was 59%. For the same stocks of the ETF, the average monthly volume growth was 6% and the average quarterly volume growth was -2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 49
Price Growth Rating: 44
SMR Rating: 58
Profit Risk Rating: 71
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
IYK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category ConsumerStaples

Category
Consumer Defensive
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of approximately $8.5 billion, a roughly 5% increase from $8.1 billion in Q1 2025. Consensus adjusted earnings per share (EPS) forecast stands at $4.74, reflecting a potential decline from prior-year levels amid pricing pressures.
Analysts expect Q1 2026 adjusted EPS of around $1.61, down from prior year levels due to softer commodity prices. Consensus revenue forecast stands at approximately $14.5 billion, reflecting a year-over-year decline.